|
|
 |
 |
| |
 Printable version |
French pharmacoepidemiological observatory of buprenorphine delivery and good use in community pharmacy |
Journal de Pharmacie Clinique. Volume 28, Number 1, 5-12, janvier-février-mars 2009, Article original
|
 Résumé
Article gratuit
|
Author(s) : FA Allaert |
Summary : Objective: to describe the buprenorphine delivery in community pharmacies and its good use in daily practice. Methods: cross sectional pharmacoepidemiological study conducted in community pharmacies. Each pharmacist was asked to include the next 10 opioid-dependant patients coming with a prescription of buprenorphine. Results: 3772 opioid-dependant patients, 35 years old among whom 73,9% were male, have been included in the study. The name of the pharmacy was written on the prescription in 67,7% of them, the average duration of the prescription was 24 days and the average dosage was 8 mg, and the intake was once a day in 78,8%. Three quarters of patients (75,5%) use the sublingual way, 14,3% inject buprenorphine and 5,3% sniff it\; 35,5% are also taking benzodiazepines\; 12,5% have more than one medical prescribers\; 4,6% have already shown false prescriptions et 12,7% have sometime some hostile reactions. The good use of buprenorphine appears statistically correlated with patient socialization. Conclusion: the good use of buprenorphine can still be improved and the pharmacist may provide an important contribution to a better practice, and especially if specific continuous training are proposed to all staff members. |
Keywords : high-dose buprenorphine, good use, epidemiology |
|
